Published On: 10/29/2024
DIA RWE 2024 Research: Presentation by David Pritchard, PhD
Target RWE Director of Data Management & Statistics, David Pritchard, PhD, recently provided an insightful video preview of his presentation at the DIA Real-World Evidence (RWE) Conference titled 'Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting.' In this session, Dr. Pritchard delves into using Negative Control Outcome studies (NCOs) as a methodological approach to ensure robust treatment group comparability, ultimately strengthening study validity and reliability in real-world research settings.
Watch the video below to gain a deeper understanding of how NCO studies can enhance the accuracy of your research, reduce bias, and elevate the overall quality of your study findings.
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
Kayla Slake
Senior Manager, Marketing
984.234.0268 ext 205
More News
-
11/26/2024
ACG 2024: Target RWE Presents Key MASH and EGIDs Data from Leading Liver Disease & Gastroenterology Real-World Registries -
11/25/2024
New Target RWE Research Validates Updated Liver Disease Terminology in Children -
11/18/2024
Target RWE Unveils Latest Developments in TARGET-Liver Disease and Cirrhosis Quality Collaborative Partnership with the American Association for the Study of Liver Diseases -
10/29/2024
DIA RWE 2024 Research: Presentation by Nuvan Rathnayaka -
10/29/2024
DIA RWE 2024 Research: Presentation by David Pritchard, PhD